Advances in structural modifications and biological activities of berberine: An active compound in traditional Chinese medicine

Mini-Reviews in Medicinal Chemistry

Volumn 11, Issue 13, 2011, Pages 1122-1129

  Huang, Z J ^a   Zeng, Y ^a   Lan, P ^a   Sun, P H ^a   Chen, W M ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Berberine; Biological activities; Structural modification

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA GLUCOSIDASE; AMYLOID BETA PROTEIN; BERBERINE; BERBERINE DERIVATIVE; DNA TOPOISOMERASE; EPSTEIN BARR VIRUS ANTIGEN; GLUTATHIONE PEROXIDASE; NORFLOXACIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RIFAMPICIN; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BACTERIAL CELL; BIOLOGICAL ACTIVITY; CELL DEATH; COPTIS; CYTOTOXICITY; DNA SYNTHESIS; DRUG STRUCTURE; INTESTINE ABSORPTION; INTESTINE INJURY; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMODIUM FALCIPARUM; REVIEW; STAPHYLOCOCCUS AUREUS; SYSTEMATIC REVIEW;

ALZHEIMER DISEASE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIMALARIALS; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; BERBERINE; DIABETES MELLITUS; DRUG DISCOVERY; DRUGS, CHINESE HERBAL; HUMANS; HYPOGLYCEMIC AGENTS; MALARIA; MEDICINE, CHINESE TRADITIONAL; MYCOSES; NEOPLASMS;

EID: 80054055026     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955711797655362     Document Type: Review

References (48)

1. Li, B.; Zhu, W.L.; Chen, K.X.; Advances in the study of berberine and its derivatives. Acta Pharm. Sin., 2008, 43, 773-787.
2. Tang, J.; Feng, Y.B.; Tsao, S.W.; Wang, N.; Curtain, R.; Wang, Y.W. Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J. Ethnopharmacol., 2009, 126, 5-17.
3. Kettmann, V.; Kostalova, D.; Hoeltje, H.D. Human topoisomerase I poisoning: docking protoberberines into a structure-based binding site model. J. Comput. Aid Mol. Des., 2004, 18, 785-796.
4. Inoue, K.; Kulsum, U.; Chowdhury, S.A.; Fujisawa, S.I.; Ishihara, M.; Yokoe, I.;Sakagami, H. Tumor-specific cytotoxicity and apoptosis-inducing activity ofberberines. Anticancer Res., 2005, 4053-4059.
5. Teresa, S.; Paulo, O.; Vilma, S.; Ed, P.; Donna, P.; Jon, H. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemother. Pharmacol., 2008, 61, 1007-1008.
6. Goncalo, C.; Pereira, F.; Branco, A.C.; Matos, P.; Donna, P.; Edward, P.; Teresa, S.; Vilma, S.; Maria, S.; Antonio, M.; Jon, H.; Paulo, O. Mitochondrially targeted effects of berberine [natural yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions. J. Pharmacol. Exp. Ther., 2007, 323, 636-649.
7. Iwasa, K.; Moriyasu, M.; Yamori, T.; Turuo, T.; Lee, D.U.; Wiegrebe, W. In vitro cytotoxicity of the protoberberine-type alkaloids. J. Nat. Prod., 2001, 64, 896-898
8. Orfila, L.; Rodriguez, M.; Colman, T.; Hasegawa, M.; Merentes, E.; Arvelo, F. Structural modification of berberine alkaloids in relation tocytotoxic activity in vitro. J. Ethnopharmacol., 2000, 71, 449-456.
9. Makhey, D.; Li, D.J.; Zhao, B.P.; Sim, S.P; Li, T.K,; Liu, A.; Liu, L.F.; LaVoiea, E. J. Substituted benzo[i]phenanthridines as mammalian topoisomerase-targeting agents. Bioorg. Med. Chem., 2003, 11, 1809-1820.
10. Cui, W.H.; Iwasa, K.; Tokuda, H.; Kashihara, A.; Mitani, Y.; Hasegawa, T.; Nishiyama, Y.; Moriyasu, M.; Nishino, H.; Hanaoka, M.; Mukai, C.; Takeda, K. Potential cancer chemopreventive activity of simple isoquinolines, 1-benzylisoquinolines, and protoberberines. Phytochemistry, 2006, 67, 70-79.
11. Zhang, W.J.; Ou, T.M.; Lu, Y.J.; Huang, Y.Y.; Wu, W.B.; Huang, Z.S.; Zhou, J.L.; Wong, K.Y.; Gu, L.Q. 9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA. Bioorg. Med. Chem., 2007, 15, 5493-5501.
12. Ma, Y.; Ou, T.M.; Hou, J.Q.; Lu, Y.J.; Tan, J.H.; Gu, L.Q.; Huang, Z.S. 9-N-Substituted berberine derivatives: Stabilization of Gquadruplex DNAand down-regulation of oncogene c-myc. Bioorg. Med. Chem., 2008, 16, 7582-7591.
13. Ma, Y.; Ou, T.M.; Tan, J.H.; Hou, J.Q.; Huang, S.L.; Gu, L.Q.; Huang, Z.S. Synthesis and evaluation of 9-O-substituted berberine derivatives containing aza-aromatic terminal group as highly selective telomeric G-quadruplex stabilizing ligands. Bioorg. Med. Chem. Lett., 2009, 19, 3414-3417.
14. Long, Y.H.; Bai, L.P.; Qin, Y.; Pang, J.Y.; Chen, W.H.; Cai, Z.W.; Xu Z.L.; Jiang, Z.H. Spacer length and attaching positiondependent binding of synthesized protoberberine dimers to doublestranded DNA. Bioorg. Med. Chem., 2006, 14, 4670-4676.
15. Yi, Z.B.; Yu, Y.; Liang, Y.Z.; Zeng, B. Evaluation of the antimicrobial mode of berberine by LC/ESI-MS combined with principal component analysis. J. Pharm. Biomed. Anal., 2007, 44, 301-304.
16. Inna, S.; Maria, M.; Kim, L.; Vladimir, S. Transfer of cationic antibacterial agents berberine, palmatine, and benzalkonium through bimolecular planar phospholipid film and Staphylococcus aureus membrane. IUBMB Life, 2001, 52, 321-324.
17. Iwasal, K.; Kamigauchil, M.; Uek, M.; Antibacterial activity and structure-activity relationships of berberine analogs. Eur. J. Med. Chem., 1996, 31, 469-478.
18. Iwasa, K.; Hye-Sook, K.; Wataya, Y.; Lee, D.U.; Antimalarial activity and structure-activity relationships of protoberberine alkaloids. Eur. J. Med. Chem., 1998, 33, 65-69.
19. Iwasa, K.; Lee, D.U.; Kang, S.I.; Wiegrebe, W. Antimicrobial activity of 8-alkyl-and 8-phenyl-substituted berberines and their 12-bromo derivatives. J. Nat. Prod., 1998, 61, 1150-1153.
20. Kim, S.H.; Lee, S.J.; Lee, J.H.; Sun, W.S.; Kim. Antimicrobial activity of 9-O-acyl-and 9-O-alkylberberrubine derivatives. Planta Med., 2002, 68, 277-81.
21. Yang, Y.; Ye, X.L.; Li, X.G.; Zhen, J.; Zhang, B.S.; Yuan, L.J. Synthesis and antimicrobial activity of 8-alkylberberine derivatives with a long aliphatic chain. Planta Med., 2007, 73, 602-604.
22. Park, K. D.; Cho, S. J.; Moon, J. S.; Kim, S. U. Synthesis and antifungal activity of a novel series of 13-(4-isopropylbenzyl)berberine derivatives. Bioorg. Med. Chem. Lett., 2010, 20, 6551-6554.
23. Siritron, S.; Bongkot, T.; Nussara, M.; Gabriele, C.; Danuta, T.; Kim, L.; Apichart, S.; Therdsak, P.; Karina, C.; Gornalle; Jennifer, L.; Becke; John B. Bremnere. Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group. Bioorg. Med. Chem., 2009, 17, 3866-3872.
24. Scarpini, E.; Scheltens, P.; Feldman, H. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol., 2003, 2, 539-547.
25. Asai, M.; Iwata, N.; Yoshikawa, A.; Aizaki, Y.; Ishiura, S.; Saido, T. C.; Maruyama, K. Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Aβ secretion. Biochem. Biophys. Res. Commun., 2007, 352, 498-502.
26. Huang, L.; Luo, Z.H.; He, F.; Shi, A.; Qin, F.F.; Li, X.S. Berberine derivatives, with substituted amino groups linked at the 9-position, as inhibitors of acetylcholinesterase/butyrylcholinesterase. Bioorg. Med. Chem. Lett., 2010, 20, 6649-6652.
27. Huang, L.; Shi, A.; He, F.; Li, X.S. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. Bioorg. Med. Chem., 2010, 18, 1244-1251.
28. Huang, L.; Luo, Z.H.; He, F.; Lu, J.; Li, X.S. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase. Bioorg. Med. Chem., 2010, 18, 4475-4484.
29. Zhou, J.Y.; Zhou, S.W. Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes. Eur. J. Pharmacol., 2010, 649, 390-397.
30. Bian, X.L.; He, L.C.; Yang, G.D. Synthesis and antihyperglycemic evaluation of various protoberberine derivatives. Bioorg. Med. Chem. Lett., 2006, 16, 1380-1383.
31. Cheng, Z.; Chen, A.F.; Wu, F.; Sheng, L.; Zhang, H.K.; Gu, M.; Li, Y.Y.; Zhang, L.N.; Hu, L.H.; Li, J.Y.; Li, J. 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models. Bioorg. Med. Chem., 2010, 18, 5915-5924.
32. Wang, Y.X.; Wang, Y.P.; Zhang, H.; Kong, W.J.; Li, Y.H.; Liu, F.; Gao, R.M.; Liu, T.; Jiang, J.D.; Song, D.Q. Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor. Bioorg. Med. Chem. Lett., 2009, 19, 6004-6008.
33. Lee, I.A.; Hyun, Y.J.; Kim, D.H. Berberine ameliorates TNBSinduced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation. Eur. J. Pharmacol., 2010, 648, 162-170.
34. Kuo, C.L.; Chi, C.W.; Liu, T.Y. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett., 2004, 203, 127-137.
35. Zhang, Q.; Piao, X.L.; Piao, X.S.; Lu, T.; Wang, D.; Kim, S.W. Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides. Food Chem. Toxicol., 2011, 49, 61-69.
36. Lu, D.Y.; Tang, C.H.; Chen, Y.H.; Wei, I.H. Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia. J. Cell. Biochem., 2010, 110, 697-705.
37. Lee, D.U.; Kang, Y.J.; Park, M.K.; Lee, Y.S.; Seo, H.G.; Kim, T.S.; Kim, C.H.; Chang. K.C. Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-a, iNOS, and IL-12 production in LPS-stimulated macrophages. Life Sci., 2003, 73, 1401-1412.
38. Yasukawa, K.; Takido, M.; Ikekawa, T.; Shimada, F.; Takeuchi, M.; Nakagawa, S. Relative inhibitory activity of berberine-type alkaloids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Chem. Pharm. Bull., 1991, 39, 1462-1465.
39. Tsukimoto, M.; Harada, H.; Degawa, M. Role of purinoceptors in immune-mediated disease (therapies targeting the P2X7 receptor). Drug Discov. Today Ther. Strateg., 2007, 4, 33-37.
40. Ferrari, D.; Pizzirani, C.; Adinolfi, E.; Lemoli, R. M.; Curti, A.; Idzko, M.; Panther, E.; Di Virgilio, F. The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol., 2006, 176, 3877-3883.
41. Lee, G.E.; Lee, H.S.; Lee, S.D.; Kim, J.H.; Kim, W.K.; Kim, Y.C. Synthesis and structure-activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists. Bioorg. Med. Chem. Lett., 2009, 19, 954-958.
42. Elford B.C. L-Glutamine influx in malaria-infected erythrocytes: a target for anti malarials. Parasitol. Today, 1986, 2, 310-312.
43. Jonathan L. V.; Daniel, K. Protoberberine alkaloids as antimalarials. J. Med. Chem., 1988, 31, 1085-1087.
44. Iwasa, K.; Kim, H.S.; Wataya, Y.; Lee, D.U. Antimalarial activity and structure-activity relationships of protoberberine alkaloids. Eur. J. Med. Chem., 1988, 33, 65-69.
45. Iwasa, K.; Nishiyama, Y.; Ichimaru, M.; Moriyasu, M.; Kim, H.S.; Wataya, Y.; Yamori, T.; Takashi, T.; Lee, D.U. Structure-activity relationships of quaternary protoberberine alkaloids having an antimalarial activity. Eur. J. Med. Chem., 1999, 34, 1077-1083.
46. Hayashi, K.; Minoda, K.; Nagaoka, Y.; Hayashi, T.; Uesatob, S. Antiviral activity of berberine and related compounds against human cytomegalovirus. Bioorg. Med. Chem. Lett., 2007, 17, 1562-1564.
47. Zhang, C.; Huang, W.L. Synthesis and antiarrhythmic activity of protoberberine quaternary ammonium compounds. J. Chin. Pharm. Univ., 2003, 34, 7-12.
48. Fu, X.C.; Hu, Y.Z.; Zhou, Q.T.; Bai, D.L. Quantitative structureactivity relationships for tetrahydroprotoberberines to interact with the dopamine D2 receptor. Chin. J. Med. Chem., 1999, 32, 111-113.